Estimating dose painting effects in radiotherapy: a mathematical model.

Tumor heterogeneity is widely considered to be a determinant factor in tumor progression and in particular in its recurrence after therapy. Unfortunately, current medical techniques are unable to deduce clinically relevant information about tumor heterogeneity by means of non-invasive methods. As a...

Full description

Bibliographic Details
Main Authors: Juan Carlos López Alfonso, Nick Jagiella, Luis Núñez, Miguel A Herrero, Dirk Drasdo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3935877?pdf=render
_version_ 1818279534611398656
author Juan Carlos López Alfonso
Nick Jagiella
Luis Núñez
Miguel A Herrero
Dirk Drasdo
author_facet Juan Carlos López Alfonso
Nick Jagiella
Luis Núñez
Miguel A Herrero
Dirk Drasdo
author_sort Juan Carlos López Alfonso
collection DOAJ
description Tumor heterogeneity is widely considered to be a determinant factor in tumor progression and in particular in its recurrence after therapy. Unfortunately, current medical techniques are unable to deduce clinically relevant information about tumor heterogeneity by means of non-invasive methods. As a consequence, when radiotherapy is used as a treatment of choice, radiation dosimetries are prescribed under the assumption that the malignancy targeted is of a homogeneous nature. In this work we discuss the effects of different radiation dose distributions on heterogeneous tumors by means of an individual cell-based model. To that end, a case is considered where two tumor cell phenotypes are present, which we assume to strongly differ in their respective cell cycle duration and radiosensitivity properties. We show herein that, as a result of such differences, the spatial distribution of the corresponding phenotypes, whence the resulting tumor heterogeneity can be predicted as growth proceeds. In particular, we show that if we start from a situation where a majority of ordinary cancer cells (CCs) and a minority of cancer stem cells (CSCs) are randomly distributed, and we assume that the length of CSC cycle is significantly longer than that of CCs, then CSCs become concentrated at an inner region as tumor grows. As a consequence we obtain that if CSCs are assumed to be more resistant to radiation than CCs, heterogeneous dosimetries can be selected to enhance tumor control by boosting radiation in the region occupied by the more radioresistant tumor cell phenotype. It is also shown that, when compared with homogeneous dose distributions as those being currently delivered in clinical practice, such heterogeneous radiation dosimetries fare always better than their homogeneous counterparts. Finally, limitations to our assumptions and their resulting clinical implications will be discussed.
first_indexed 2024-12-12T23:34:52Z
format Article
id doaj.art-105b740db235414c98bbca630a8e2a3a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T23:34:52Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-105b740db235414c98bbca630a8e2a3a2022-12-22T00:07:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8938010.1371/journal.pone.0089380Estimating dose painting effects in radiotherapy: a mathematical model.Juan Carlos López AlfonsoNick JagiellaLuis NúñezMiguel A HerreroDirk DrasdoTumor heterogeneity is widely considered to be a determinant factor in tumor progression and in particular in its recurrence after therapy. Unfortunately, current medical techniques are unable to deduce clinically relevant information about tumor heterogeneity by means of non-invasive methods. As a consequence, when radiotherapy is used as a treatment of choice, radiation dosimetries are prescribed under the assumption that the malignancy targeted is of a homogeneous nature. In this work we discuss the effects of different radiation dose distributions on heterogeneous tumors by means of an individual cell-based model. To that end, a case is considered where two tumor cell phenotypes are present, which we assume to strongly differ in their respective cell cycle duration and radiosensitivity properties. We show herein that, as a result of such differences, the spatial distribution of the corresponding phenotypes, whence the resulting tumor heterogeneity can be predicted as growth proceeds. In particular, we show that if we start from a situation where a majority of ordinary cancer cells (CCs) and a minority of cancer stem cells (CSCs) are randomly distributed, and we assume that the length of CSC cycle is significantly longer than that of CCs, then CSCs become concentrated at an inner region as tumor grows. As a consequence we obtain that if CSCs are assumed to be more resistant to radiation than CCs, heterogeneous dosimetries can be selected to enhance tumor control by boosting radiation in the region occupied by the more radioresistant tumor cell phenotype. It is also shown that, when compared with homogeneous dose distributions as those being currently delivered in clinical practice, such heterogeneous radiation dosimetries fare always better than their homogeneous counterparts. Finally, limitations to our assumptions and their resulting clinical implications will be discussed.http://europepmc.org/articles/PMC3935877?pdf=render
spellingShingle Juan Carlos López Alfonso
Nick Jagiella
Luis Núñez
Miguel A Herrero
Dirk Drasdo
Estimating dose painting effects in radiotherapy: a mathematical model.
PLoS ONE
title Estimating dose painting effects in radiotherapy: a mathematical model.
title_full Estimating dose painting effects in radiotherapy: a mathematical model.
title_fullStr Estimating dose painting effects in radiotherapy: a mathematical model.
title_full_unstemmed Estimating dose painting effects in radiotherapy: a mathematical model.
title_short Estimating dose painting effects in radiotherapy: a mathematical model.
title_sort estimating dose painting effects in radiotherapy a mathematical model
url http://europepmc.org/articles/PMC3935877?pdf=render
work_keys_str_mv AT juancarloslopezalfonso estimatingdosepaintingeffectsinradiotherapyamathematicalmodel
AT nickjagiella estimatingdosepaintingeffectsinradiotherapyamathematicalmodel
AT luisnunez estimatingdosepaintingeffectsinradiotherapyamathematicalmodel
AT miguelaherrero estimatingdosepaintingeffectsinradiotherapyamathematicalmodel
AT dirkdrasdo estimatingdosepaintingeffectsinradiotherapyamathematicalmodel